What is the recommended treatment for a second-degree atrioventricular (AV) block?

Treatment for Second-Degree AV Block

The treatment of second-degree AV block depends critically on whether it is Mobitz Type I or Type II, the presence of symptoms, and the anatomic location of the block—with permanent pacemaker implantation indicated for symptomatic second-degree AV block regardless of type, while asymptomatic Mobitz Type I at the AV node level generally does not require pacing. 1

Acute Management

Symptomatic Second-Degree AV Block

For patients with symptomatic second-degree AV block causing hemodynamic compromise, atropine 0.5 mg IV every 3-5 minutes (maximum 3 mg total) is the first-line acute treatment, particularly when the block is at the AV nodal level. 1

• Atropine is specifically effective for Mobitz Type I block complicating inferior myocardial infarction (Class I indication). 1
• Atropine should not be relied upon for Mobitz Type II block or blocks with wide QRS complexes, as these are typically infranodal and unlikely to respond to vagolytic therapy. 1
• Doses <0.5 mg may paradoxically worsen bradycardia and should be avoided. 1
• Use atropine cautiously in acute coronary ischemia, as increased heart rate may worsen ischemia. 1

Alternative Pharmacologic Agents

• Beta-adrenergic agonists (isoproterenol, dopamine, dobutamine, or epinephrine) may be considered for symptomatic second- or third-degree AV block when coronary ischemia is unlikely (Class IIb). 1
• Aminophylline may be considered for AV block in the setting of acute inferior MI (Class IIb). 1

Temporary Pacing

Temporary transvenous pacing is reasonable for symptomatic second-degree AV block refractory to medical therapy (Class IIa). 1

• Transcutaneous pacing may be considered as a bridge until transvenous or permanent pacing can be established. 1
• Temporary pacing should not delay permanent pacemaker implantation when indicated, as temporary pacing carries increased risks. 2

Permanent Pacemaker Indications

Class I Indications (Definitive)

Permanent pacemaker implantation is indicated for:

1. Any second-degree AV block with symptomatic bradycardia, regardless of type or anatomic site (Level of Evidence: B). 1

2. Second-degree AV block associated with arrhythmias or medical conditions requiring drugs that cause symptomatic bradycardia. 1

3. Second- or third-degree AV block during exercise in the absence of myocardial ischemia (indicating His-Purkinje disease with poor prognosis). 1

4. Advanced second-degree AV block (two or more consecutive blocked P waves) with symptoms at any anatomic level. 1

Class IIa Indications (Reasonable)

Permanent pacing is reasonable for:

• Asymptomatic second-degree AV block at intra- or infra-His levels found on electrophysiological study (Level of Evidence: B). 1

• First- or second-degree AV block with pacemaker syndrome symptoms or hemodynamic compromise (Level of Evidence: B). 1

Class III (Not Indicated)

Permanent pacing is NOT indicated for:

• Asymptomatic Mobitz Type I (Wenckebach) second-degree AV block at the supra-His (AV node) level (Level of Evidence: C). 1

• AV block expected to resolve (drug toxicity, Lyme disease, transient vagal tone increases) in the absence of symptoms (Level of Evidence: B). 1

Critical Distinctions Between Block Types

Mobitz Type I (Wenckebach)

• Progressive PR prolongation before the blocked beat is the defining characteristic. 1
• Block is typically at the AV node level and often benign, especially with narrow QRS. 1
• Does not require pacing if asymptomatic and at the AV nodal level. 1
• However, recent evidence suggests that even asymptomatic elderly patients with Mobitz Type I may benefit from pacing, particularly when occurring during daytime hours, as pacing was associated with improved survival. 1, 3

Mobitz Type II

• Constant PR intervals before and after the blocked beat with sudden failure of conduction. 1, 4
• Block is typically infranodal (His-Purkinje system), especially with wide QRS. 1
• High risk of progression to complete heart block and sudden cardiac death. 1
• Pacing is indicated even if asymptomatic (Class IIa), particularly in the setting of acute MI. 1
• Important diagnostic pitfall: True Mobitz Type II is commonly overdiagnosed; atypical Wenckebach, vagal surges with simultaneous sinus slowing, and concealed His extrasystoles can mimic Type II block. 4, 5

2:1 AV Block

• Cannot be classified as Type I or Type II based on ECG alone. 1, 5
• Requires observation for longer rhythm strips showing 3:2 or other conduction patterns, or electrophysiological study to determine the level of block. 5

Special Considerations

Drug-Related AV Block

Recent evidence challenges the traditional view that drug-related AV block is always reversible. 2

• The American guidelines recommend permanent pacing for symptomatic second- or third-degree AV block in patients on stable, necessary antiarrhythmic or beta-blocker therapy without waiting for drug washout. 1, 2
• True drug-induced AV block is rare; most cases represent drug-revealed underlying conduction system disease with high recurrence rates after drug discontinuation. 2
• Early permanent pacing should be recommended, especially in frail elderly patients and those requiring ongoing bradycardic/antiarrhythmic therapy for atrial arrhythmias. 2

Vagally Mediated AV Block

• Characterized by paroxysmal AV block with simultaneous sinus slowing. 6
• Benign condition that should be managed as neurally mediated syncope, not with permanent pacing in asymptomatic patients. 6
• Important to distinguish from true Mobitz Type II, which requires stable sinus rate for diagnosis. 4, 6, 5

Reversible Causes

If symptomatic AV block persists despite treatment of reversible causes (electrolyte abnormalities, Lyme disease, drug toxicity), permanent pacing is indicated. 1

• For cardiac sarcoidosis with second- or third-degree AV block, permanent pacing with defibrillator capability is reasonable without waiting for reversibility (Class IIa). 1

Common Pitfalls

1. Misdiagnosing atypical Wenckebach as Mobitz Type II: Always verify stable sinus rate and truly constant PR intervals. 4, 5

2. Delaying pacing for "reversible" drug-related block: Most cases recur and represent underlying disease. 2

3. Using atropine for wide-QRS or Mobitz Type II block: These infranodal blocks are unlikely to respond. 1

4. Assuming all Mobitz Type I is benign: Elderly patients and those with wide QRS may have infranodal disease requiring pacing. 1, 3

5. Prolonged temporary pacing instead of permanent implantation: Temporary pacing carries increased risks and should not delay definitive therapy. 2